The question is not whether testosterone declines with age. It does. Serum total testosterone levels fall by one to two percent per year beginning in a man's early thirties. By age fifty, many men are operating below the threshold where clinical intervention is warranted. The relevant question is whether the decline is affecting function and whether intervention is appropriate, considering the full clinical picture.
Testosterone replacement therapy is a medical intervention with a defined mechanism and a documented evidence base. There is a specific patient profile that benefits from it. It is not a lifestyle upgrade and it is not appropriate for every man who feels less capable than he did at age thirty-five. It is necessary to understand what the therapy does, who it helps, and what the protocol actually involves before making a clinical decision.
This article covers the mechanism of testosterone deficiency, the clinical criteria for TRT, the evidence-based outcomes, and a properly managed protocol.
Key Takeaways
-
Testosterone replacement therapy is indicated for men with confirmed hypogonadism, which is defined as low serum testosterone levels accompanied by symptoms. Symptoms alone are insufficient.
-
The clinical threshold for low testosterone is typically a total testosterone level below 300 ng/dL in the morning on two separate occasions, though free testosterone and sex hormone-binding globulin (SHBG) levels provide a more complete picture.
-
TRT does not restore endogenous testosterone production. It replaces circulating testosterone exogenously. This distinction is important for men who wish to preserve fertility.
-
Properly managed TRT includes baseline and ongoing monitoring of hematocrit, PSA, estradiol, and lipid panels, not just testosterone levels.
-
The difference between a well-managed TRT protocol and an unmanaged one is safety.
What Testosterone Actually Does
Testosterone is a steroid hormone produced primarily by Leydig cells in the testes in response to the release of luteinizing hormone by the pituitary gland. In men, it is the primary androgen responsible for a range of physiological functions that extend well beyond reproductive health.
At the tissue level, testosterone binds to androgen receptors in skeletal muscle, bone, the brain, cardiovascular tissue, and adipose cells. Adequate receptor activation has several downstream effects, including protein synthesis in muscle tissue, maintenance of bone mineral density, stimulation of erythropoietin for erythropoiesis, regulation of mood and cognitive function through neurosteroid pathways, and modulation of fat distribution and insulin sensitivity.
When circulating testosterone is chronically low, these functions become impaired in proportion to the degree of deficiency. The result is a gradual reduction in functional output across multiple systems simultaneously. There is reduced muscle mass despite consistent training. Increased body fat, particularly visceral fat. There is also cognitive fog that affects recall and processing speed. Low libido. Fatigue that is not resolved by rest. Reduced competitive drive.
Each of these symptoms has other potential causes. None of them, in isolation, confirms testosterone deficiency. That is why testing is necessary. Testing is the starting point.
Clinical Criteria for TRT
A clinical case for testosterone replacement therapy requires two things: documented low serum testosterone levels and symptoms consistent with hypogonadism. Either condition alone is not sufficient for responsible prescribing.
Laboratory Criteria: According to the Endocrine Society, male hypogonadism is diagnosed when total testosterone is below 300 ng/dL on two separate morning blood tests. Morning testing is essential because testosterone levels are highest early in the day and naturally decline as the day progresses.
Total testosterone alone does not provide the full picture. Much of testosterone is bound to sex hormone-binding globulin (SHBG), rendering it unavailable to the body. Free testosterone is often a better indicator of hormonal status. For this reason, a thorough hormone evaluation should include measurements of total testosterone, free testosterone, SHBG, LH, FSH, and estradiol.
Symptomatic criteria: The American Urological Association and the Endocrine Society require the presence of symptoms and low testosterone levels for a hypogonadism diagnosis. Common symptoms include low libido, erectile dysfunction, fatigue, a depressed mood, difficulty concentrating, a loss of muscle mass, an increase in body fat, and a reduction in bone density.
However, low testosterone alone is not enough for a diagnosis. Testosterone replacement therapy (TRT) is generally reserved for men with clinically low testosterone levels and meaningful symptoms that affect their quality of life.
What a Properly Managed Protocol Looks Like
Testosterone replacement therapy is an ongoing clinical relationship that requires active monitoring and periodic adjustments.
Delivery Method: The most common delivery formats are intramuscular or subcutaneous injections of testosterone cypionate or enanthate; transdermal gels or creams; and subcutaneous pellets.
Starting Dose and Titration: A typical starting dose of injectable testosterone cypionate is 100 to 200 milligrams (mg) per week. It is administered as a single weekly injection or split into two smaller injections to reduce peak-to-trough fluctuation.
Monitoring parameters: A responsible TRT protocol monitors the following at baseline and at regular intervals: total and free testosterone, hematocrit (TRT stimulates red blood cell production and elevated hematocrit increases the risk of clotting), estradiol (testosterone converts to estradiol via aromatase; elevated estradiol causes fluid retention, mood changes, and gynecomastia), prostate-specific antigen (PSA) for men over forty (monitoring is standard), and lipid panel.
Estradiol management: Testosterone naturally converts into estradiol at different rates depending on the person. Some men undergoing testosterone replacement therapy (TRT) may develop elevated estradiol levels and require treatment to maintain hormonal balance, while others do not.
Fertility Considerations: Testosterone replacement therapy (TRT) can reduce the body's natural production of testosterone and sperm, which may affect fertility. Men who wish to preserve their fertility should discuss options such as human chorionic gonadotropin (hCG) with their healthcare provider. hCG may support sperm production during treatment.
Who Should Not Start TRT
Contraindications to testosterone replacement therapy (TRT) include:
-
Active prostate cancer
-
Elevated PSA without urological evaluation
-
Breast cancer
-
Untreated severe sleep apnea
-
Hematocrit above 54 percent
-
Uncontrolled heart failure
-
A recent cardiovascular event
These are not necessarily permanent disqualifiers. Rather, they are factors that require clinical evaluation before a protocol is initiated.
The Practical Decision
Testosterone replacement therapy is appropriate when the following two conditions are met: serum testosterone is confirmed to be low by laboratory criteria based on properly timed blood draws, and the patient's symptoms are consistent with the functional impairment caused by the testosterone deficiency.
Under competent medical supervision, TRT is a legitimate clinical intervention with a well-characterized evidence base and a manageable risk profile when both conditions are met. However, when either condition is absent, intervention is not clinically indicated.
TRT produces the clearest benefit for men who were functioning at a high level, noticed a specific and meaningful decline, tested their levels and found them objectively low, and initiated a properly supervised protocol. This distinction is important to understand before making a decision.
Disclaimer: This article is intended for general informational and educational purposes only and does not constitute medical advice. Testosterone replacement therapy requires a clinical evaluation, laboratory confirmation, and ongoing medical supervision by a licensed healthcare professional. Consult a qualified healthcare professional before starting or changing any hormone therapy.
Frequently Asked Questions
What should I do if I think I have low testosterone?
Get a blood test in the morning to measure your total testosterone, free testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estradiol. One data point is not enough. The clinical standard before any intervention is initiated is two separate morning blood draws confirming low total testosterone.
Will TRT shut down my natural production permanently?
TRT suppresses the HPT axis and reduces endogenous production while you are on it. Many men who discontinue TRT recover natural production over several months. However, recovery is not guaranteed and is influenced by the duration of use, age, and pre-existing testicular function. Discontinuation protocols involving hCG and SERMs can support recovery.
How long does it take for TRT to produce noticeable results?
Libido and mood often improve within the first two to four weeks. Changes in body composition, strength, and bone density develop over months, not weeks. Sustained benefits require sustained therapy. TRT is not an acute intervention.
Is TRT safe in the long term?
For men with hypogonadism who are properly monitored, the evidence supports long-term safety under appropriate clinical supervision. The key variables are hematocrit management, cardiovascular risk assessment, and PSA monitoring. Unmonitored TRT carries risks that monitored TRT does not.
What is the difference between TRT and anabolic steroid use?
TRT restores circulating testosterone levels to the range that a man's body would naturally produce if his HPT axis were functioning properly. In contrast, anabolic steroid use involves supraphysiological doses intended to produce effects beyond normal physiological function. The dose, intent, clinical oversight, and risk profile are all different.
Reviewed by
